Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole XR in Restless Legs Syndrome
NCT00197080Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00197080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197080.